Differential expression of immune activation markers in T cells from patients with multiple myeloma - Takeaways - MDSpire

Differential expression of immune activation markers in T cells from patients with multiple myeloma

  • By

  • Jiaoya Lin

  • Xin Zhang

  • Yifei Zhao

  • Lan Luo

  • Hong Yuan

  • Ling Zhong

  • May 20, 2026

  • 0 min

Share

  • 1

    Multiple myeloma (MM) is characterized by malignant plasma cell proliferation and remains incurable despite treatment advancements.

  • 2

    Bone marrow samples from MM patients showed increased CD4+ and CD8+ central memory T cells, while effector memory T cells were significantly decreased.

  • 3

    MM patients exhibited higher frequencies of specific activation markers in T cell subsets compared to healthy controls, indicating altered immune activation.

  • 4

    The study highlights the need for further research to understand the functional significance of T cell activation profiles in MM.

  • 5

    Understanding T cell immune competence is essential for optimizing immunotherapeutic strategies in multiple myeloma patients.

Original Source(s)

Differential expression of immune activation markers in T cells from patients with multiple myeloma

  • by Jiaoya Lin, Xin Zhang, Yifei Zhao, Lan Luo, Hong Yuan, Ling Zhong

  • May 20, 2026

Related Content

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship